Effect of insulin glargine and nph insulin on quality of life in patients with type 2 diabetes mellitus

被引：0
|
作者：
Gupta, K. S. [1 ]
Gupta, U. [1 ]
机构：
[1] Maulana Azad Med Coll, New Delhi, India
来源：
VALUE IN HEALTH | 2007年 / 10卷 / 03期
关键词：
D O I：
10.1016/S1098-3015(10)68751-7
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A70 / A70
页数：1
相关论文
共 50 条
  • [41] Less symptomatic hypoglycemia with insulin glargine compared to NPH in patients with type 2 diabetes.
    Fonseca, V
    Bell, D
    Mecca, T
    DIABETOLOGIA, 2001, 44 : A207 - A207
  • [42] Less symptomatic hypoglycemia with bedtime insulin glargine (Lantus®) compared to bedtime NPH insulin in patients with type 2 diabetes
    Fonseca, V
    Bell, D
    Mecca, T
    DIABETES, 2001, 50 : A112 - A112
  • [43] Nocturnal glucose metabolism after a single bedtime injection of insulin glargine or NPH insulin in patients with type 2 diabetes
    Fischer, Britta
    Soydan, Nedim
    Eckhard, Michael
    Ehl, Julia
    Kunz, Clemenis
    Bretzel, Reinhard G.
    Linn, Thomas
    DIABETES, 2006, 55 : A111 - A111
  • [44] Insulin glargine or NPH combined with metformin in type 2 diabetes: the LANMET study
    H. Yki-Järvinen
    R. Kauppinen-Mäkelin
    M. Tiikkainen
    M. Vähätalo
    H. Virtamo
    K. Nikkilä
    T. Tulokas
    S. Hulme
    K. Hardy
    S. McNulty
    J. Hänninen
    H. Levänen
    S. Lahdenperä
    R. Lehtonen
    L. Ryysy
    Diabetologia, 2006, 49 : 442 - 451
  • [45] Insulin glargine or NPH combined with metformin in type 2 diabetes:: the LANMET study
    Yki-Järvinen, H
    Kauppinen-Mäkelin, R
    Tiikkainen, M
    Vähätalo, M
    Virtamo, H
    Nikkilä, K
    Tulokas, T
    Hulme, S
    Hardy, K
    McNulty, S
    Hänninen, J
    Levänen, H
    Lahdenperä, S
    Lehtonen, R
    Ryysy, L
    DIABETOLOGIA, 2006, 49 (03) : 442 - 451
  • [46] A meta-analysis of clinical therapeutic effect of insulin glargine and insulin detemir for patients with type 2 diabetes mellitus
    Zhuang, Y. G.
    Peng, H.
    Huang, F.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2013, 17 (19) : 2566 - 2570
  • [47] Insulin therapy in type 2 diabetes: A prospective 18 month comparison of insulin glargine and NPH insulin in patients with a multiple injection regimen
    Siegmund, T
    Born, T
    Weber, S
    Usadel, KH
    Schumm-Draeger, PM
    DIABETES, 2003, 52 : A456 - A456
  • [48] A Randomized Clinical Trial of Insulin Glargine and Aspart, Compared to NPH and Regular Insulin in Children with Type 1 Diabetes Mellitus
    Rostami, Parastoo
    Setoodeh, Aria
    Rabbani, Ali
    Nakhaei-Moghadam, Maryam
    Najmi-Varzaneh, Farnaz
    Rezaei, Nima
    IRANIAN JOURNAL OF PEDIATRICS, 2014, 24 (02) : 173 - 178
  • [49] COMPARISON OF COSTS OF THE INSULIN TREATMENT OF TYPE 2 DIABETES MELLITUS WITH INSULIN GLARGINE AND INSULIN DETEMIR
    Guisasola, Alvarez F.
    Puente, Mauricio D.
    Coscolin, Garcia T.
    Terres, Rubio C.
    VALUE IN HEALTH, 2010, 13 (07) : A287 - A287
  • [50] Immunogenicity of LY2963016 insulin glargine and Lantus® insulin glargine in Chinese patients with type 1 or type 2 diabetes mellitus
    Wang, Weimin
    Song, Xiang
    Lou, Ying
    Du, Liying
    Zhu, Dalong
    Zhou, Zhiguang
    DIABETES OBESITY & METABOLISM, 2022, 24 (06): : 1094 - 1104
12345